APA (7th ed.) Citation

Weiss, K. H., Członkowska, A., Hedera, P., & Ferenci, P. (2018). WTX101 - an investigational drug for the treatment of Wilson disease. Expert opinion on investigational drugs, 27(6), . https://doi.org/10.1080/13543784.2018.1482274

Chicago Style (17th ed.) Citation

Weiss, Karl Heinz, Anna Członkowska, Peter Hedera, and Peter Ferenci. "WTX101 - an Investigational Drug for the Treatment of Wilson Disease." Expert Opinion on Investigational Drugs 27, no. 6 (2018). https://doi.org/10.1080/13543784.2018.1482274.

MLA (9th ed.) Citation

Weiss, Karl Heinz, et al. "WTX101 - an Investigational Drug for the Treatment of Wilson Disease." Expert Opinion on Investigational Drugs, vol. 27, no. 6, 2018, https://doi.org/10.1080/13543784.2018.1482274.